INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Data sources
SEC FORM 41h ago
HOUSE PTR1h ago
SEC 13F1h ago
ROBINHOOD CHAIN1h ago
Public company

Q/C TECHNOLOGIES, INC.

QCLSCIK 0001321834

EDGAR filingsOpen in network
Price$0.34
1 year-89.0%
Disclosed transactions7
Buys / sells0 / 0
Max Insider Score21
Connections with evidence7

QCLS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
VS
Voss Chelsea SierraDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2835 · In Vitro & In Vivo Diagnostic Substances · Nov 4, 2026
  • ← Insider ofevidence
    Voss Chelsea SierraDirector · Apr 15, 2026
  • ← Insider ofevidence
    Silverman JoshuaDirector, Executive Chairman · Apr 15, 2026
  • ← Insider ofevidence
    White Billy JoeDirector · Apr 15, 2026
  • ← Insider ofevidence
traded Apr 13, 2026
+2d
SEC FORM 4

Evidence

9
GM
Glass MitchellDirector, Chief Medical Officer
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

21
SJ
Silverman JoshuaDirector, Executive Chairman
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
162.2K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
SJ
Silverman JoshuaDirector, Executive Chairman
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
100.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
FS
Friscia StephenDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
WJ
White Billy JoeDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

9
BB
Bernstein BruceDirector
QCLSQ/C TECHNOLOGIES, INC.
Grant or award
A—
50.0K sh
Apr 13, 2026Apr 15, 2026
traded Apr 13, 2026
+2dSEC FORM 4

Evidence

Friscia Stephen
Director · Apr 15, 2026
  • ← Insider ofevidence
    Bernstein BruceDirector · Apr 15, 2026
  • ← Insider ofevidence
    Glass MitchellDirector, Chief Medical Officer · Apr 15, 2026